- Home
- ABSI
ABSI
Absci Corporation
as 07-26-2024 4:00pm EST
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | 335.9M | IPO Year: | 2021 |
| Target Price: | $8.40 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.11 - $6.72 | Next Earning Date: | 08-14-2024 |
| Revenue: | $5,347,000 | Revenue Growth: | -13.72% |
| Revenue Growth (this year): | 18.78% | Revenue Growth (next year): | 213.24% |
Stock Insider Trading Activity of Absci Corporation (ABSI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | ABSI | CFO / CBO | Jun 13 '24 | Sell | $4.98 | 19,859 | $98,891.86 | 384,751 | SEC Form 4 |
| Phoenix Venture Partners II LP | ABSI | 10% Owner | May 22 '24 | Sell | $4.40 | 3,100,000 | $13,640,000.00 | 11,279,522 | SEC Form 4 |
| Redmile Group, LLC | ABSI | Director | Mar 1 '24 | Buy | $4.50 | 222,222 | $999,999.00 | 8,253,316 | SEC Form 4 |
Latest Absci Corporation News
ABSI Breaking Stock News: Dive into ABSI Ticker-Specific Updates for Smart Investing
Zacks
14 days ago
Entrada Therapeutics (TRDA) Moves 10.4% Higher: Will This Strength Last?
MT Newswires
15 days ago
KeyBanc Adjusts Price Target on Absci to $6 From $8, Maintains Overweight Rating
GlobeNewswire
16 days ago
Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
GlobeNewswire
23 days ago
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MT Newswires
24 days ago
Morgan Stanley Initiates Absci at Overweight With $7 Price Target
Simply Wall St.
a month ago
Institutional investors own a significant stake of 46% in Absci Corporation (NASDAQ:ABSI)
Insider Monkey
a month ago
Is Absci Corporation (NASDAQ:ABSCI) the Best Halal Stock According to Hedge Funds?
GlobeNewswire
a month ago
Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
Compare ABSI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABSI Absci Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.